Hoffmann-La Roche Ltd. v. Canada (Minister of Health) et al., (2006) 354 N.R. 281 (FCA)
Linked as:
Extract
Hoffmann-La Roche Ltd. v. Canada (Minister of Health) et al., (2006) 354 N.R. 281 (FCA)
No longer available (Autolink)
See the full content of this document
This document cites
- AstraZeneca Canada Inc. v. Canada (Minister of Health), 2004 FC 736
- Ferring Inc. v. Canada (Attorney General) et al., (2003) 310 N.R. 186 (FCA)
- R. v. Schwartz (D.L.), (2004) 329 N.R. 197 (Motion)
- Bristol-Myers Squibb Canada Inc. v. Canada (Attorney General) et al., (2001) 199 F.T.R. 142 (TD)
- Abbott Laboratories et al. v. Canada (Minister of Health) et al., (2004) 320 N.R. 37 (FCA)
